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Deer antlers are bony appendages that are annually cast and rapidly regrown in a seasonal process coupled to
the reproductive cycle. Due to the uniqueness of this process among mammals, we reasoned that a fundamental
characterization of antler progenitor cell behavior may provide insights that could lead to improved strategies
for promoting bone repair. In this study, we investigated whether white-tailed deer antlerogenic progenitor cells
(APC) conform to basic criteria defining mesenchymal stromal cells (MSC). In addition, we tested the effects of
the artificial glucocorticoid dexamethasone (DEX) on osteogenic and chondrogenic differentiation as well as
the degree of apoptosis during the latter. Comparisons were made to animal-matched marrow-derived MSC.
APC and MSC generated similar numbers of colonies. APC cultures expanded less rapidly overall but expe-
rienced population recovery at later time points. In contrast to MSC, APC did not display adipogenic in vitro
differentiation capacity. Under osteogenic culture conditions, APC and MSC exhibited different patterns of
alkaline phosphatase activity over time. DEX increased APC alkaline phosphatase activity only initially but
consistently led to decreased activity in MSC. APC and MSC in osteogenic culture underwent different time
and DEX-dependent patterns of mineralization, yet APC and MSC achieved similar levels of mineral accrual in
an ectopic ossicle model. During chondrogenic differentiation, APC exhibited high levels of apoptosis without a
reduction in cell density. DEX decreased proteoglycan production and increased apoptosis in chondrogenic
APC cultures but had the opposite effects in MSC. Our results suggest that APC and MSC proliferation and
differentiation differ in their dependence on time, factors, and milieu. Antler tip APC may be more lineage-
restricted osteo/chondroprogenitors with distinctly different responses to apoptotic and glucocorticoid stimuli.
Introduction
Fracture healing is a multistage regenerative processthat under optimal conditions can restore bone function
without generating permanent scar tissue.1,2 Successful re-
pair depends on the type and extent of injury; the body’s
bone repair program often cannot restore function after large
segmental losses due to disease or trauma.3
While bone repair and regeneration in most mammals
follows this bounded paradigm, a rare exception is the deer
antler, the only example of complete, repeated organ re-
generation in an adult mammal.4 Antlers are bony append-
ages that in most species regrow, attain a fully mineralized,
largely devitalized state, and are then cast off after the
rutting season.4 This seasonal process is coupled to the re-
productive cycle and associated with fluctuations in levels of
circulating androgens.5 Due to their size, nutritional re-
quirements, and role in sparring and fighting contests be-
tween rival males, antlers serve as outward indications of
mate quality.6,7 Annual regeneration requires some of the
fastest rates of bone growth in nature, exceeding 2 cm/day in
some species.6
Antlers elongate through endochondral ossification oc-
curring in growth centers at the distal end of each antler
tine.8 Within each growth center, antlerogenic progenitor
cells (APC) reside in a niche called the reserve mesen-
chyme, where undifferentiated APC undergo rapid prolif-
eration as well as robust apoptosis.9,10 More proximally,
APC undergo chondrogenic differentiation while osteoblasts
are derived from cells in the perivascular niches that inter-
calate cartilage trabeculae.
Although the antler transcends barriers that limit our
ability to promote regeneration in our own species, little is
known of APC. As antler regrowth is thought to be due to
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the de novo generation of progenitor cells (rather than
through de- or transdifferentiation of existing cells), it is
widely believed that APC are one or more populations of
multipotent cells.11,12 Whether APC can definitively be
considered ‘‘stem’’ or ‘‘progenitor’’ cells awaits further
characterization.
Cells derived from antler tip APC generate bone and
cartilage in vivo, yet we are aware of only a few peer-
reviewed studies that have examined the mesenchymal lin-
eage differentiation potential of APC.9,13 We reasoned that a
fundamental characterization of APC behavior may provide
insights that could lead to improved strategies for promoting
bone repair.
In this study, we set out to test whether heterogeneous
populations of white-tailed deer antler tip APC conform to
basic criteria defining mesenchymal stromal cells (MSC),
namely self-renewal and multipotency. We compared col-
ony formation, cell expansion rates, and in vitro and in vivo
differentiation capacities of reserve mesenchyme APC to
animal-matched phalangeal marrow-derived MSC. We also
investigated the effects of the glucocorticoid dexamethasone
(DEX) on osteogenesis in vitro. In chondrogenic cultures,
we explored the effects of DEX on cell number, apoptosis,
and matrix production.
Materials and Methods
Specimen acquisition
Cells were obtained from three wild, *2- to 4-year-old
white-tailed bucks (Odocoileus virginianus) in early Au-
gust, toward the end of the rapid regrowth phase in
Southeast Michigan. Specimen acquisition conformed to
institutional animal care and use standards and state
wildlife policies.
To obtain MSC, red marrow was flushed from phalanges
and adherent cells cultured in the complete medium: Dul-
becco’s modified Eagle’s medium (Gibco, Life Technolo-
gies, Grand Island, NY), 10% fetal bovine serum (FBS;
Gibco), 100 units/mL penicillin, 100 mg/mL streptomycin,
and 0.25 mg/mL amphotericin B. APC were harvested from
the antler tip reserve mesenchyme, which was dissected,
minced, and plated in the complete medium.
As cellular antler tissue is only available on a seasonal
basis, comparisons were made using both fresh and frozen
cells. To freeze, confluent cells were detached using 0.25%
trypsin-EDTA (Gibco), resuspended at 5 · 106 cells/mL in
FBS, and 10% dimethyl sulfoxide. After 24 h at - 80C in a
Mr Frosty cell freezing container (Nalge Nunc International,
Rochester, NY), cells were transferred to liquid nitrogen.
Thawed passage 1 cells were cultured in the complete me-
dium supplemented with 6mM l-glutamine and without
amphotericin B.
Cell enumeration over time
First passagecellswereseededon96-well plates (3200/cm2).
Between 1 and 8 days, relative cell number was estimated
by measuring the fluorescent intensity of a nuclear binding
dye (CyQUANT; Life Technologies) at 485 nm excitation/
530 nm emission. Results were corrected using CyQUANT-
only control wells. Cell enumeration was conducted at the
same time each day.
Colony formation
First passage cells were seeded on six-well plates at low
density (17/cm2). After 14 days of culture in the complete
medium, cells were fixed in 1% glutaraldehyde and stained
with 0.1% Crystal Violet. Colonies visible to the naked eye
were counted manually.
Osteogenesis
First passage fresh or thawed cells were plated at 5000/cm2
in the complete medium. At 70–80% confluence, the me-
dium was supplemented with 0.1 mm DEX, 0.05mM
l-ascorbic acid 2-phosphate (Sigma-Aldrich Co. LLC,
St. Louis, MO), and 10mM b-glycerophosphate (Sigma,
St. Louis, MO).14 In a subset of thawed cells, DEX was
omitted. Unless stated otherwise, the osteogenic medium
contained DEX.
To detect mineralized nodules, cultures were stained in
1% Alizarin Red-S and solubilized in 0.5N HCl + 5% SDS.
Solubilized stain was transferred to 24-well or 96-well
plates. Optical densities (OD) at 415 nm were normalized to
those of the buffer. To correct for cell number, parallel wells
were stained with Crystal Violet. Crystal Violet was solu-
bilized in a 1:1 solution of ethanol and 1% Triton X-100,
and the OD was measured at 562 nm.
Alkaline phosphatase activity was measured using
Moreau’s modification of Lowry’s method.15 Briefly, cells
were lysed in a Triton/glycine buffer and homogenized by
repeated pipetting. Lysates were transferred to 96-well
plates and a 12.5mM pNPP substrate was added. Samples
were incubated for 90min at 37C and 1N NaOH was then
added to stop the reaction. The resultant pNP content was
quantified by measuring the OD at 405 nm and corrected
using buffer-only control wells. Enzyme activity was ex-
pressed as pmol of pNP divided by incubation time and
lysate protein content (BCA assay; Pierce/Thermo Fisher
Scientific, Rockford, IL).
Adipogenesis
First passage fresh or thawed cells were plated at 5000/cm2
in the complete medium. At 95–100% confluence
(designated day 0), the medium was replaced with the
adipogenesis induction medium (AIM): high-glucose
DMEM (Gibco), 10% FBS, 1% Pen-Strep, 1 mM DEX
(Sigma), 0.2mM indomethacin (Sigma), 1.7 mM recombi-
nant human insulin (Sigma), and 0.5mM 1-methyl-3-
isobutylxanthine (Sigma). On day 3, the AIM was replaced
with the adipogenesis maintenance medium (AMM): high-
glucose DMEM (4.5 g/L), 10% FBS, 1% Pen-Strep, and
1.7 mM recombinant human insulin.16 For the first 12 days of
culture, cells were exposed to a total of three 3-day AIM
treatments separated by a 1-day AMM treatment. From day
13 to 21, AMM was used exclusively and replaced every
3–4 days. To detect lipid droplets, cells were fixed overnight
in 10% neutral buffered formalin (NBF), incubated in 60%
isopropanol, and stained in 0.5% Oil Red-O.
Chondrocyte induction
Chondrogenic differentiation experiments were per-
formed in micromass cultures.17 250,000 cells were pelleted
in 15-mL conical tubes and cultured in the chondrogenic
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medium: high-glucose DMEM, 1% Pen-Strep, 10 ng/mL,
recombinant human TGFb3 (Sigma), 0.1mMDEX, 50mg/mL
l-ascorbic acid 2-phosphate, 40mg/mL l-proline (Sigma),
and 1% ITS+ (BD Biosciences, Sparks, MD).
After 14 days, hypertrophic induction medium: high-
glucose DMEM, 1% Pen-Strep, 50ng/mL thyroxine (Sigma),
1 nM DEX, 20mM b-glycerophosphate, 50mg/mL l-ascorbic
acid 2-phosphate, 40mg/mL l-proline, and 1% ITS+ .
After 28 days, micromasses were fixed in 10% NBF, par-
affin embedded, and 6-mm-thick sections were cut and
mounted onto glass slides. In a subset of thawed cells,
DEX was omitted from both chondrogenic and hypertrophic
media.
Micromass collagen content was evaluated using Van
Gieson’s Stain. Proteoglycan content was visualized with
Safranin-O and verified using Alcian Blue (pH 2.5) on
separate sections. Alizarin Red staining was also performed
for micromasses in the DEX effects portion of the study.
To measure apoptosis and cell number within micro-
masses, slides were dual-labeled using a TUNEL-Hoechst
kit (Click-iT TUNEL assay; Molecular Probes/Life Tech-
nologies, Eugene, OR). Microscopy and image capture were
conducted using a Zeiss Axiovert 200M (Carl Zeiss Mi-
croscopy, LLC, Thornwood, NY). For each section, three
images were taken in the same field of view. First, an auto-
exposed brightfield image was taken to estimate the tissue
area. Next, Hoeschst-stained and TUNEL image were cap-
tured sequentially using standardized exposure times. Image
analysis was carried out using ImageJ software (National
Institutes of Health, Bethesda, MD). Mean TUNEL image
grayscale intensities were normalized to cells per brightfield
image area.
Ectopic ossicle growth model
Passage 1 APC and MSC from three deer were thawed
and expanded in culture. To validate the model, MSC were
also harvested from the long bone marrow of 5-week-old
C57BL/6 mice as described previously.18 Deer cells were
cultured in the complete medium and C57/BL6 MSC in
a-MEM (Gibco) containing 100U/mL penicillin, 100mg/
mL streptomycin, 20% FBS, and 10 nM DEX.19
Cells were seeded at 18000/mm3 on Type I collagen
sponges (Gelfoam; Pharmacia&Upjohn Co., New York,
NY). ‘‘Blank’’ sponges were soaked in the complete me-
dium. Sponges were implanted subcutaneously in 4-week-
old immunodeficient mice (Athymic Nude; Charles River
Laboratories International, Inc., Wilmington, MA). After 6
weeks, implants were removed, fixed for 48 h in 10% NBF,
and kept in 70% ethanol preparatory to histology.
Using microcomputed tomography (mCT), implants were
scanned in air and reconstructed on 18 mm voxels (GE
Healthcare Preclinical Imaging, London, ON, Canada).
Analysis was performed using GE Microview software on
three-dimensional regions of interest (ROI) interpolated
from two-dimensional splines. After generating image his-
tograms to estimate mineralized tissue grayscales, a global
threshold was applied to each ROI, and mineral content and
density were calculated.
After mCT, implants were demineralized in 10% EDTA,
paraffin embedded, and 7-mm sections were mounted onto
glass slides. Proteoglycan content was visualized using Al-
cian Blue-Periodic Acid-Schiff stain (Poly Scientific R&D
Corp., Bay Shore, NY). Putative osteoclasts were identified
using a TRAP detection kit (Sigma).
Statistical analysis
As each experiment involved a small sample size (2–3
biological replicates), multiple experimental replicates (3–
12) were performed for each assay. Generalized linear
mixed models, which take into account nested data struc-
tures and repeated measures, were used for comparisons
(SPSS; IBM Corp., Armonk, NY). For fresh and thawed cell
models, ‘‘celltype’’ was a fixed effect and ‘‘animal’’ was a
random effect. For the DEX study, ‘‘DEX treatment,’’
‘‘celltype,’’ and a ‘‘DEX · celltype’’ interaction were fixed
effects with ‘‘animal’’ again as a random effect. As ossicle
mCT involved APC, MSC, and blanks, ‘‘celltype’’ was used
as a fixed effect; no random effect was considered. Statis-
tical comparisons were limited to implants with detectable
mineralized tissue. Values more than 2.5 standard deviations
from the mean were omitted. Figures show least squared
means and standard deviations.
Results
Cell enumeration over time
Rapid antler growth rates in vivo prompted us to compare
APC and MSC expansion in culture. While MSC numbers
increased before reaching a plateau at 6 days, APC numbers
declined between 1 and 4 days and then increased between
5 and 8 days (Fig. 1A). Contrary to expectations, APC did
not exhibit greater in vitro proliferative capacity compared
to MSC.
Colony-forming units
The ability of single cells to form colonies is a measure of
self-renewal, a key progenitor cell trait.20 The mean num-
bers of visible colonies generated by APC and MSC were
similar, but APC demonstrated more interanimal variability
(Fig. 1B).
Adipogenic differentiation
The capacity to differentiate into adipocytes, osteoblasts,
and chondrocytes is another characteristic of MSCs.21 After
21 days of exposure to adipogenic media, both fresh and
thawed MSC displayed widespread intracellular Oil Red-O-
positive lipid droplets. No lipid droplets were observed for
either fresh or thawed APC at the same time point (Fig. 2).
Osteogenic differentiation
We performed osteogenic differentiation of APC and
MSC in culture using both fresh and thawed cells. In a
separate experiment, we measured the effects of the glu-
cocorticoid DEX on osteogenic differentiation in thawed
cells.
APC and MSC displayed different patterns of alkaline
phosphatase activity over time. In both fresh and thawed
cells, APC activity was greater than MSC at earlier time
points while the reverse was true by day 14 in thawed cells
(Fig. 3). In fresh cells, the APC activity was greater than
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MSC at day 16 (Fig. 3A). However, MSC activity in-
creased over time in the same stepwise manner seen in
thawed cells.
DEX affected APC and MSC alkaline phosphatase ac-
tivity differently (Fig. 3C). DEX increased the APC activity
at day 7 but had no significant effect at days 10 or 14. In
MSC, however, DEX consistently led to decreased alkaline
phosphatase activity.
APC and MSC in the osteogenic culture underwent
different patterns of mineralization as well. In thawed cells
cultured with DEX, by days 21/22, MSC had greater cell
number-corrected mineralization, while no significant
difference was seen by days 28/30 (Fig. 4E, F). On the
other hand, MSC maintained greater mineralization at day
30 in fresh cells (Fig. 4D). APC consistently had fewer
cells in fresh and thawed cultures compared to MSC
(Fig. 4A–C).
DEX influenced APC and MSC mineralization in dif-
ferent ways (Fig. 4F). At day 21, DEX reduced minerali-
zation in both APC and MSC. By day 28, DEX led to
increased mineralization in APC (APC +DEX: 0.232 –
0.08, APC -DEX: 0.142 – 0.06, p = 0.02) but did not sig-
nificantly alter Alizarin Red content in MSC at this time
point ( p = 0.23) (Fig. 4F).
DEX significantly lowered cell number in MSC at day 28,
but the absolute difference was small (Fig. 4C). DEX also
lowered APC cell number at day 28, but the difference was
not statistically significant ( p = 0.09).
Chondrogenic differentiation
We used a micromass model to induce chondrogenic
differentiation in thawed APC and MSC. We also explored
whether the robust apoptosis seen in the reserve mesen-
chyme could be recapitulated in these high-density cultures.
In a separate experiment, chondrogenic differentiation and
apoptosis were investigated in thawed APC and MSC with
and without DEX.
Evidence of a chondrogenic phenotype was found in both
APC and MSC micromasses (Fig. 5). However, matrix
composition and the effect of DEX depended on cell type.
Safranin-O staining showed a widespread distribution in
MSC micromasses, but staining was faint in APC micro-
masses (data not shown). Alcian Blue staining verified the
presence of proteoglycans in the latter (Fig. 5, middle
panel). DEX qualitatively increased the intensity and dis-
tribution of Alcian Blue and Safranin-O (data not shown) in
MSC micromasses while having the opposite effect in APC
micromasses. Van Gieson’s staining confirmed collagen
production throughout APC and MSC micromasses and was
not affected by DEX.
Alizarin Red-S staining was performed to investigate
matrix mineralization during chondrocytic differentiation
(Fig. 5, right panels). Again, DEX affected APC and MSC
FIG. 2. Adipogenic differentiation of
thawed cells. MSC exhibited Oil Red-O-
positive lipid droplets, whereas none were
apparent for APC under these conditions.
Color images available online at www
.liebertpub.com/tea
FIG. 1. Comparison of antlerogenic progenitor cells
(APC) and mesenchymal stromal cell (MSC) cell number
and colony formation. (A) Relative cell number over time as
measured by optical density (OD). *p£ 0.05 APC versus
MSC at each time point. Eight to 16 wells per group per
time point, n = 3 bucks. (B) Colony formation at day 14
(n = 3, p = 0.89).
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in seemingly opposite ways. MSC Alizarin Red staining was
qualitatively more robust with DEX, whereas the reverse
was apparent in APC.
Cellularity of APC and MSC micromasses also differed.
In thawed cell micromasses, APC displayed significantly
more cells per matrix area than MSC (Fig. 6A, B). DEX did
not affect the number of APC cells per area ( p = 0.58) but
increased cellularity in MSC (MSC +DEX 11.4 – 0.39 vs.
7.1 – 0.35 in untreated MSC, p < 0.001).
Compared to MSC, APC micromasses were more apo-
ptotic. In TUNEL-stained images, APC micromasses had
greater mean grayscale intensities and proportion of nonzero
grayscale pixels compared to MSC (Fig. 6C–F). In APC
micromasses, DEX increased both measures of apoptosis
while reducing or having no effect on MSC.
Ectopic ossicle formation
Ectopic ossicle formation assesses cell osteogenic dif-
ferentiation in a murine model assumed to be more rep-
resentative of the native cell milieu than cell culture
plastic.22 As described in the previous literature, C57BL/6
cell-seeded implants generated a mineralized shell sur-
rounding a marrow-like region containing erythrocytes,
likely host-derived (histological data not shown). Although
APC- and MSC-seeded scaffolds did not generate an
apparent marrow region, histological analysis revealed
proteoglycan-positive regions containing buried osteocyte-
like cells (Fig. 7A–C), as well as the presence of multinu-
cleated TRAP-positive cells (Fig. 7D–F). No TRAP-positive
cells were apparent in blank ossicles.
Although lower than in ossicles formed by BL/6 MSC
(data not shown), mineral content was similar in APC and
cervid MSC ossicles ( p = 0.63) (Fig. 7G, H). MSC had a
slightly greater mineral density compared to either APC or
blanks (Fig. 7G, H).
Discussion
We initiated this study as an exploration of white-tailed
deer APC in terms of basic criteria defining MSCs. Our
results indicate that in addition to self-renewal and multiple
lineage differentiation, reserve mesenchyme-derived APCs
exhibit a phenotype distinct from animal-matched marrow-
derived progenitor cells.
Both APC and MSC demonstrated clonogenicity or the
ability to generate colonies in a density-independent
manner in culture.20 The lack of difference in mean APC
and MSC colony numbers suggests that overall self-
renewal capacity is conserved across different connective
tissue progenitors in a regionally restricted white-tail
population. On the other hand, the greater APC standard
deviation indicates a greater variation in self-renewal of
antlerogenic cells from deer to deer compared to marrow-
derived MSC or could reflect differences in antler growth
stages in individual animals.
White-tailed deer antlers regrow rapidly, about 0.25 in-
ches (6.35mm) per day.23 In vitro, however, APCs from
these deer expanded less rapidly than MSC overall. Inter-
estingly, after 5 days of decline in a monolayer culture, APC
numbers began to recover.
Cells were cultured from late summer antlers when rapid
growth had begun to abate. However, proliferation of red
deer (Cervus elaphus) APC in vitro is independent on the
stage of antler regrowth during which the cells were har-
vested.24 It is conceivable that the situation is similar in the
white-tailed deer as well.
Slower APC expansion in the monolayer culture may
instead have been due to one or more disadvantageous
components of the culture system—initial plating density,
oxygen tension, the lack of APC-specific mitogenic factors
in the medium, and so on. For example, APC in a micromass
culture consistently exhibited a greater cell number per
matrix area compared to MSC. These data raise the possi-
bility that APC mitogenesis may be more sensitive to milieu
FIG. 3. Alkaline phosphatase activity in fresh and thawed
cells. (A) Fresh cell alkaline phosphatase activity (n = 2
bucks). (B) Thawed cell activity (n = 3). (C) Alkaline
phosphatase activity in thawed cells cultured with or without
dexamethasone (DEX) (n = 2). * or line: p £ 0.05, #: p£ 0.1.
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FIG. 4. Relative cell num-
ber and mineralization during
osteogenic differentiation.
(A) Fresh cell number
(Crystal Violet OD, n = 2
bucks). (B) Thawed cell
numbers (n = 3). (C) Thawed
cell numbers with and with-
out DEX (n = 2). (D) Fresh
cell mineral (Alizarin Red-S
OD normalized by Crystal
Violet, 24-well plate). (E)
Thawed cell mineral (96-well
plate). (F) Thawed cell min-
eral, with and without DEX
(96-well plate). * or line:
p£ 0.05. Line + #: p £ 0.1.
FIG. 5. Chondrogenic
micromass histology (buck 1
cells, 200· magnification).
Color images available
online at www.liebertpub
.com/tea
PHENOTYPE OF ANTLEROGENIC PROGENITOR CELLS AND DEER MARROW-DERIVED MSC 1421
FIG. 6. Chondrogenic
micromass cellularity and
apoptosis. (A, B) Cells per
area for thawed cells (n = 3
bucks) and thawed cells with
or without DEX (n = 2). (C,
D) TUNEL grayscale inten-
sity normalized by cells per
area for thawed cell and
thawed cells with or without
DEX. Different scales due to
lower permeabilization of
tissue in latter study. (E, F)
Another measure of apopto-
sis: percent of pixels with
nonzero grayscale, thawed
cell and thawed cells with or
without DEX. (G, H) Images
of TUNEL stain, buck 1 APC
and MSC, 200· magnifica-
tion. Six sections per mass.
* or line: p £ 0.05.
FIG. 7. Histology and
microcomputed tomography
(mCT) of ectopic ossicles
(n = 3 bucks). (A–C) Alcian
Blue-Periodic Acid-Schiff
(400· ): APC, MSC, blank.
Arrows show embedded
cells. (D–F) TRAP staining
(400· ): APC, MSC, blank.
Arrows show TRAP-positive
cells. (G, H) mCT data: tissue
mineral content and tissue
mineral density. Line:
p£ 0.05. Color images avail-
able online at www.liebertpub
.com/tea
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compared to MSC (i.e., monolayer versus three-dimensional
micromass).
In terms of cell potency, our results suggest that, com-
pared to MSC, antler tip reserve mesenchyme APC are more
lineage-restricted osteo/chondrogenic progenitors, with little
adipogenic capacity. This result may reflect that adipose
tissue is not a primary antler constituent while it is present in
the phalangeal marrow space. In the case of stem cells,
differentiation is generally limited to the lineages present in
the tissue of origin.25 However, as heterogeneous cell cul-
tures were used here, further investigation will be needed to
determine whether differences in APC and MSC adipo-
genesis were exaggerated by the presence of committed
adipocytic precursors in the latter culture. These findings
contrast with those of Rolf et al. and Berg et al., who re-
ported positive Oil Red-O staining in fallow deer (Dama
dama) and red deer (C. elaphus) APC, respectively, after
exposure to the adipogenic medium.9,13 Besides the use of
different deer species, possible sources of discrepancy be-
tween our results and those of other workers include the
differentiation of a STRO-1 + cell subpopulation by Rolf
et al. (rather than a heterogeneous population) and the
harvest of cells from the cranial frontal crest (instead of the
antler tip reserve mesenchyme) by Berg et al. The contrast
in adipogenic capacity between our results and the latter
study suggests that APC multipotency may depend on the
anatomical location of the niche in which these cells reside.
Under osteogenic conditions, APC alkaline phosphatase
activity was higher than that of MSC for the first 10 days in
culture. This suggests higher responsiveness of APC to os-
teogenic factors, perhaps due to a greater degree of intrinsic
osteo/chondrogenic commitment compared to MSC. Despite
higher initial alkaline phosphatase activity, APC minerali-
zation was delayed until later time points or reduced relative
to MSC, perhaps reminiscent of the delay in complete
mineralization that occurs in the antler after full regrowth is
achieved.
DEX consistently inhibited mineralization in MSC cul-
tures, but its effects on APC mineralization were time de-
pendent. This suggests that DEX affects APC-derived
osteoblasts in a manner dependent on differentiation stage,
consistent with the studies of glucocorticoid action on os-
teoblasts.26 In contrast, DEX consistently reduced markers
of early and late osteoblast differentiation in cervid MSC
cultures.
In the murine ectopic ossicle formation model, APC-
seeded scaffolds generated a similar amount of mineralized
matrix compared to MSC after 6 weeks of implantation.
This contrasts with our in vitro results in which thawed APC
were only able to achieve statistically similar mineralization
compared to MSC on a per-cell basis at later time points and
in the presence of DEX. Fresh APC were not able to match
MSC mineralization under the same conditions.
As with osteogenesis, APC and MSC undergoing chon-
drogenesis responded differently to DEX. While DEX led to
increased proteoglycan content and mineralization in MSC-
derived micromasses, the opposite was true for those from
APC. These results demonstrate that, in vitro, DEX can play
a role in supporting chondrocytic differentiation in MSC
while reducing it in APC.
In addition to influencing matrix production in APC and
MSC micromass, DEX treatment led to differences in cel-
lularity and apoptosis. For APC, DEX fostered more robust
apoptosis but had no significant impact on cellularity.
In MSC micromass, DEX led to greater matrix production,
increased cellularity, and lower apoptosis over un-
treated micromasses. This suggests that, in MSC undergoing
chondrogenesis, DEX enhances both proliferation and dif-
ferentiation, although these effects are likely dependent on
the stage of cell lineage progression.
Antler regrowth is associated with hormone levels
changing throughout the mating cycle. However, it has been
difficult to determine which factors directly regulate APC
proliferation and differentiation. Factors such as testoster-
one, whose fluctuations are closely associated with the
antler cycle,27 failed to promote mitogenesis in antler cell
cultures.28 On the other hand, it is unclear whether IGF-1,
which stimulates antler cell proliferation in vitro,28,29 is the
key stimulatory factor in antler growth.24
DEX can promote or suppress bone cell proliferation and
differentiation directly and through interactions with hor-
mones such as IGF-1.26,30,31,32 DEX can also reduce antler
cell proliferation in vitro.29 In APC cultures, we found that
DEX reduced markers of chondrogenic differentiation
while promoting apoptosis. High levels of apoptosis have
been reported in the reserve mesenchyme, adjacent to re-
gions of active chondrogenesis.10 This suggests that factors
such as glucocorticoids might contribute to the shifting
balance between progenitor proliferation and differen-
tiation in the antler as it undergoes regeneration. Addi-
tionally, an inverse relationship between apoptosis and
chondrogenesis raises the possibility that apoptosis may
help maintain a population of nondifferentiating APC
within the reserve mesenchyme. Compensatory prolifera-
tion, in which caspases released from apoptotic bodies act
as mitogenic factors, is one means by which apoptosis can
contribute to tissue homeostasis.33
The observed pattern of time, factor, and milieu depen-
dence of APC proliferation and differentiation may reflect a
system of regulation required to confine antler growth to a
specific anatomical and temporal range. Antler regrowth
does not proceed automatically in response to antler casting,
it is initiated by seasonally determined signaling.34 Com-
plete mineralization of the antler is delayed until circulating
androgens peak during the fall rutting season, after it is fully
regrown.5 Moreover, antler regrowth occurs concurrently
with bone resorption elsewhere in body, indicating a dif-
ferential responsiveness to circulating factors in the antler
compared to other bone tissue.7
We have demonstrated that APC and cervid marrow-
derived MSC differ in terms of proliferative capacity, dif-
ferentiation, apoptotic potential, and hormone responsiveness.
As knowledge of the APC phenotype improves, a compelling
avenue of future research would be the elucidation of the
mechanisms behind the properties and behavior of these cells.
A thorough understanding of the antler’s unique process of
regeneration would be of great value in guiding the devel-
opment of novel skeletal regenerative therapies.
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